Improving health for older adults with early-stage breast cancer after treatment
Implementation of a Geriatric Care Survivorship Intervention in Older Adults Who Have Completed Curative Intent Therapy for Early-Stage Breast Cancer
This study is testing a new support program to help older adults who have finished treatment for early-stage breast cancer improve their overall health and well-being.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT05928325 on ClinicalTrials.gov |
What this trial studies
This trial evaluates a geriatric care survivorship intervention aimed at enhancing the overall health of older adults who have completed curative treatment for stage I-III breast cancer. The study involves comprehensive geriatric assessments and survivorship visits to address physical, mental, and emotional health. Researchers will measure the impact of this intervention on quality of life, cognitive function, healthcare utilization, and caregiver satisfaction over a period of 6 to 12 months post-chemotherapy. The goal is to reduce health burdens and improve well-being in this population.
Who should consider this trial
Good fit: Ideal candidates are adults aged 65 and older who have recently completed chemotherapy for stage I-III breast cancer.
Not a fit: Patients with significant medical conditions that prevent participation in the intervention may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the quality of life and overall health outcomes for older breast cancer survivors.
How similar studies have performed: Other studies have shown promising results with similar geriatric care interventions, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * \>= 65-years-old * Histologically confirmed Stage I, II or III breast cancer (if the patient has had more than one breast cancer, the most recent diagnosis) * Within 8 (+/- 14 days) weeks of completing a chemotherapy regimen for breast cancer either as standard-of-care or on a study (can be receiving concomitant radiation, HER-2 targeted agents and/or endocrine therapy) * English or Spanish speaking * Able to provide written, informed consent * Willing and able to meet all study requirement * CAREGIVER ELIGIBILITY: \>= 18-years-old * CAREGIVER ELIGIBILITY: Ability to complete required study procedures Exclusion Criteria: * The presence of significant medical conditions that in the physician's (either the patient's primary oncologist of the study principal investigator) judgement preclude participation in the exercise intervention
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Meghan Karuturi, MD — M.D. Anderson Cancer Center
- Study coordinator: Meghan Karuturi, MD
- Email: mskaruturi@mdanderson.org
- Phone: (713) 563-0714
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.